MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75 | +17.2% | 1,732 | -1.6% | 0.00% | 0.0% |
| Q2 2023 | $64 | -3.0% | 1,760 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $66 | -17.5% | 1,770 | -0.3% | 0.00% | -25.0% |
| Q4 2022 | $80 | -99.9% | 1,776 | -16.8% | 0.00% | -33.3% |
| Q3 2022 | $149,000 | -17.7% | 2,135 | -20.7% | 0.01% | +20.0% |
| Q2 2022 | $181,000 | -18.1% | 2,694 | +0.2% | 0.01% | 0.0% |
| Q1 2022 | $221,000 | -51.2% | 2,689 | -12.9% | 0.01% | -44.4% |
| Q4 2021 | $453,000 | -16.4% | 3,087 | +0.7% | 0.01% | -25.0% |
| Q3 2021 | $542,000 | +4.6% | 3,065 | -4.4% | 0.01% | +20.0% |
| Q2 2021 | $518,000 | +61.4% | 3,205 | +119.1% | 0.01% | +42.9% |
| Q4 2020 | $321,000 | +32.1% | 1,463 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $243,000 | +45.5% | 1,463 | 0.0% | 0.01% | +50.0% |
| Q2 2020 | $167,000 | – | 1,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |